Boston Scientific (BSX) Reports In-Line Q3 EPS, Offers Q4 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mail
Get Alerts BSX Hot Sheet
Price: $43.84 +2.60%
Revenue Growth %: +1.0%
Financial Fact:
Restructuring charges: 5M
Today's EPS Names:
SMXT, NRIX, VFS, More
Revenue Growth %: +1.0%
Financial Fact:
Restructuring charges: 5M
Today's EPS Names:
SMXT, NRIX, VFS, More
Join SI Premium – FREE
Boston Scientific (NYSE: BSX) reported Q3 EPS of $0.31, in-line with the analyst estimate of $0.31. Revenue for the quarter came in at $2.22 billion versus the consensus estimate of $2.21 billion.
GUIDANCE:
Boston Scientific sees Q4 2017 EPS of $0.32-$0.35, versus the consensus of $0.34. Boston Scientific sees Q4 2017 revenue of $2.345-2.375 billion, versus the consensus of $2.33 billion.
For earnings history and earnings-related data on Boston Scientific (BSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nurix Therapeutics, Inc. (NRIX) Reports Q3 EPS of $4.73
- Humana leads Managed Care winners in new CMS Star Ratings - Evercore
- Can broadening earnings growth sustain the equity upcycle? JPM weighs in
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
